1. Mitochondrial matters in Parkinson disease: introduction

   • George H. Sack Jr.

   OriginalPaper 29 December 2009 Pages: 465 - 467

2. The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease

   • Teresa G. Hastings

   OriginalPaper 05 December 2009 Pages: 469 - 472

3. Mitochondrial quality control: insights on how Parkinson’s disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis

   • Ruben K. Dagda
   • Charleen T. Chu

   OriginalPaper 10 December 2009 Pages: 473 - 479

4. The mitochondrial kinase PINK1, stress response and Parkinson’s disease

   • Marina Jendrach
   • Suzana Gispert
   • Georg Auburger

   OriginalPaper Open access 26 November 2009 Pages: 481 - 486

5. Mitochondrial dysfunction in mouse models of Parkinson’s disease revealed by transcriptomics and proteomics

   • Desmond J. Smith

   OriginalPaper Open access 05 December 2009 Pages: 487 - 491

6. Parkinson’s disease and mitochondrial complex I: a perspective on the Ndi1 therapy

   • Mathieu Marella
   • Byoung Boo Seo
   • Akemi Matsuno-Yagi

   OriginalPaper 11 November 2009 Pages: 493 - 497

7. The PINK1/Parkin pathway: a mitochondrial quality control system?

   • Alexander J. Whitworth
   • Leo J. Pallanck

   OriginalPaper 05 December 2009 Pages: 499 - 503

8. PET studies of cerebral metabolism in Parkinson Disease

   • William J. Powers

   OriginalPaper 11 November 2009 Pages: 505 - 508

9. Mitochondrial respiratory dysfunction and mutations in mitochondrial DNA in PINK1 familial Parkinsonism

   • Sergio Papa
   • Anna Maria Sardanelli
   • Claudia Piccoli

   OriginalPaper 11 November 2009 Pages: 509 - 516

10. Brain mitochondrial dysfunction and oxidative damage in Parkinson’s disease

    • Ana Navarro
    • Alberto Boveris

    OriginalPaper 14 November 2009 Pages: 517 - 521